Facilitate the Transition From Passive Feeding to Active Feeding in Preterm Infants Through Early Play (ALIJEU)

January 11, 2019 updated by: Centre Hospitalier Intercommunal Creteil
The approach described here is based both on theoretical concepts and on the work of several teams of researchers. By positioning the baby and the appropriate adult, a speech bath, a sustained look and an expressive face, it is hypothesized that this early communication exercise will significantly improve the transition from passive feeding, active feeding of the premature child, from a qualitative and quantitative point of view.

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

59

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ile De France
      • Créteil, Ile De France, France, 94000
        • CHI Créteil

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 1 year (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Premate newborn with an age inferior to 32 weeks of amenorrhea at birth

Description

Inclusion Criteria:

  • Age of child at birth: <32 WA justified by the greater prevalence of oral disorders in these children.
  • Age of the child at the start of the study: 35 WA, ie at the beginning of the establishment of active feeding within the unit.

Exclusion Criteria:

  • Children with oral malformations
  • Contra-indication to the realization to the ALIJEU (infection in progress, hemodynamic instability, etc.)
  • Medical contraindications to oral diet

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Experimental group
patient who can benefit from the ALIJEU for certain meals

The intervention concerns the passage from the passive feed (gastric tube) to the active feed (breast, feeding bottle).

We propose to set up a pleasant moment just before his meal. This is a practical exercise of a few minutes.

The aim of this special moment is to facilitate child-adult exchanges, improve active food intake and reduce the length of hospital stay.

Group of witnesses
patient who did not benefit from the ALIJEU

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
age at the stoppage of enteral nutrition
Time Frame: 37 weeks of gestation
37 weeks of gestation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Duration of feeding
Time Frame: 37 weeks of gestation
Duration of the feeding in case of early game play
37 weeks of gestation
Quantities drunk
Time Frame: 37 weeks of gestation
Evaluate the quantities drunk in case of early game play
37 weeks of gestation
Awakening
Time Frame: 37 weeks of gestation
Duration of the the newborn's waking state at the time of suckling
37 weeks of gestation
Visual analogic scale for Satisfaction from 0 to 10
Time Frame: 37 weeks of gestation
Assessing the satisfaction of the ALIJEU practice for the mother and the care team
37 weeks of gestation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 19, 2017

Primary Completion (Actual)

May 1, 2018

Study Completion (Actual)

July 30, 2018

Study Registration Dates

First Submitted

April 4, 2018

First Submitted That Met QC Criteria

August 27, 2018

First Posted (Actual)

August 29, 2018

Study Record Updates

Last Update Posted (Actual)

January 15, 2019

Last Update Submitted That Met QC Criteria

January 11, 2019

Last Verified

January 1, 2019

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • ALIJEU

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Feeding Behavior

Clinical Trials on Implementation of ALIJEU

3
Subscribe